Health2 days ago
Next-Gen CAR-T Therapy Shows Promise for Refractory Leukemia Patients
Research indicates that the next-generation CAR-T cell therapy, known as rapcabtagene autoleucel, demonstrates significant promise for patients suffering from refractory B-cell acute lymphoblastic leukemia. Data from...